D, S., DO, C., A, Z., MS, T., AM, D., GA, G., . . . C, T. (2022). Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review. In vivo (Athens, Greece), 36(1), 40. https://doi.org/10.21873/invivo.12674
Chicago Style (17th ed.) CitationD, Serban, et al. "Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review." In Vivo (Athens, Greece) 36, no. 1 (2022): 40. https://doi.org/10.21873/invivo.12674.
MLA (9th ed.) CitationD, Serban, et al. "Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review." In Vivo (Athens, Greece), vol. 36, no. 1, 2022, p. 40, https://doi.org/10.21873/invivo.12674.
Warning: These citations may not always be 100% accurate.